Arch Pharmalabs Limited, a under cirp public limited company, was established on 02 April 1993 in Mumbai, Maharashtra, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24231MH1993PLC150891. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹3,000.00 Cr and a paid-up capital of ₹156.48 Cr.
Formerly known as Sibra Pharmaceuticals Limited, Avant Papers Private Limited. It upholds a compliant status. Employing 412 professional, Its leadership includes Vikas Bijay Kedia (Company Secretary), Sunil Mansukhlal Pitroda (Director), Anshul Gupta (Irp/Rp/Liquidator). Past directors included Shantilal Dalichand Jain, Vikas Bijay Kedia, Rajiv Sarman Shukla. It holds ₹5,668.24 Cr open charges and ₹311.84 Cr settled loans. Its latest AGM occurred on 29 December 2023, with the balance sheet filed on 31 March 2023. It is based at Unit No. 301,302 And 303, H Wing 3Rd Floor, Tex Centre ,, Off Saki Vihar Road, Chandivali, Andheri East, Mumbai, Mumbai, Maharashtra, 400072.
U24231MH1993PLC150891
150891
02 April 1993
₹3,000.00 Cr
₹156.48 Cr
Roc Mumbai
Unlisted
Under Cirp
Explore comprehensive insights into Arch Pharmalabs Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vikas Bijay Kedia | Company Secretary | 18 Nov 2017 | Current |
| Sunil Mansukhlal Pitroda | Director | 02 May 2017 | Current |
| Anshul Gupta | Irp/Rp/Liquidator | 30 Apr 2025 | Current |
| Ajit Annu Kamath | Managing Director | 01 Nov 2003 | Current |
| Rajendra Padmanabhan Kaimal | Whole-Time Director | 01 Nov 2003 | Current |
| Ashish Mohan Ujagare | Whole-Time Director | 14 Jun 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 15 Mar 2013 | Past |
| Pramod Abcsdd | Company Secretary | 30 Dec 2015 | Past |
| Pramod Abcsdd | Nominee Director | 30 Nov 2009 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2011 | Past |
| Pramod Abcsdd | Nominee Director | 08 Apr 2008 | Past |
| Pramod Abcsdd | Additional Director | 29 Dec 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Arch Pharmalabs Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.29% increase. The company also saw a substantial improvement in profitability, with a 112.3% increase in profit. The company's net worth Soared by an impressive increase of 39.39%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Arch Pharmalabs had a promoter holding of 58.13% and a public holding of 41.87%. The company had 3 Subsidiaries and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹56,682,400,000.00
₹3,118,437,500.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Mar 2022 | Others | ₹32.00 Cr | Open |
| 20 Jul 2021 | Others | ₹0.50 M | Open |
| 27 May 2021 | Others | ₹200.00 Cr | Open |
| 04 Dec 2017 | Others | ₹200.00 Cr | Open |
| 27 Sep 2013 | Others | ₹582.30 Cr | Open |
Explore comprehensive loan charge details -
Arch Pharmalabs has a workforce of 412 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Arch Pharmalabs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arch Pharmalabs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Anshul Gupta was appointed as a IRP/RP/Liquidator was appointed as a IRP/RP/Liquidator on 30 Apr 2025 & has been associated with this company since 6 months 27 days . was documented.
Arch Pharmalabs Limited last Annual general meeting of members was held on 29 Dec 2023 as per latest MCA records. was recorded as a recent event.
Progress on Arch Pharmalabs Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai. was documented.
Progress on A charge with Others amounted to Rs. 32.00 Cr with Charge ID 100571158 was registered on 29 Mar 2022. was documented.
A charge with Others amounted to Rs. 0.05 Cr with Charge ID 100463954 was registered on 20 Jul 2021. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 200.00 Cr with Charge ID 100464383 was registered on 27 May 2021. was documented.
/PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the....
RBI's corporate debt restructuring cell's failure rate in servicing bad loans in the banking sector was 43% until June against 36% a year ago.
The CIN of Arch Pharmalabs Limited is U24231MH1993PLC150891.
Arch Pharmalabs Limited is headquartered at Unit No. 301,302 And 303, H Wing 3Rd Floor, Tex Centre ,, Off Saki Vihar Road, Chandivali, Andheri East, Mumbai, Mumbai, Maharashtra, 400072.
Arch Pharmalabs Limited was incorporated on 02 April 1993.
The current directors of Arch Pharmalabs Limited are
The primary industry of Arch Pharmalabs Limited is Manufacturing.
Arch Pharmalabs Limited is unlisted.
The authorized capital of Arch Pharmalabs Limited is ₹3,000.00 Cr, and the paid-up capital is ₹156.48 Cr.
The compliance status of Arch Pharmalabs Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX